Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin as adjunctive treatment for chronic nonbacterial prostatitis
IRCT20180103038196N7Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of gabapentin in Prostatodynia (CP/CPPS), sponsored by Islamic Azad University. Primary endpoint: Reducing pain in chronic non-bacterial prostatitis. Started Feb 2018; status: completed.
02
Drugs
gabapentin
03
Conditions
Prostatodynia (CP/CPPS)
Beyond the preview
Go deeper on IRCT20180103038196N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180103038196N7.